Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bawat Water Technologies AB: BAWAT Announces Q4 Report 2023

Hørsholm, Denmark, February 21, 2024 – Bawat Water Technologies AB (BAWAT) today announces its Q4  Report for 2023. The report is available on Bawat’s website (investor.bawat.com) BAWAT is a leading supplier of sustainable ballast water treatment technology and services. BAWAT was listed on Nasdaq First North Premier Growth Market in Stockholm in March 2022. Doubling Order Intake and profit margin Y-o-Y and Full year 2024 guidance   Q4 2023 · Order intake in Q4 2023 elevated the full year order intake to SEK 41.8m (Guidance SEK 40-50m), a significant 131% increase from

Annual General Meeting of AB Volvo

AB Volvo (publ) (“Volvo”) gives notice to attend the Annual General Meeting at Konserthuset, Götaplatsen, Göteborg, Wednesday, March 27, 2024, at 3.00 p.m.Volvo warmly welcomes its shareholders to the Annual General Meeting. The main entrance of Konserthuset opens for registration at 2.00 p.m. and the Annual General Meeting begins at 3.00 p.m. Coffee and cakes will be served in connection with the Annual General Meeting. A shareholder may participate in the Annual General Meeting at the venue (in person or represented by a proxy) or through advance voting (postal voting). Please see the

GJF01 - Key information relating to partial redemption of bond issue

Issuer: Gjensidige Forsikring ASAISIN of bond loan: NO0010720378Date of redemption: 28 February 2024Redemption amount: MNOK 263Outstanding loan amount after redemption: MNOK 241Redemption price: 100.364 The buy-back of NOK 263 million of GJF01 will be done in conjunction with the issuance of a new subordinated Tier 2 bond issue (ISIN: NO0013167189) on 28 February 2024. The partial buy-back will be written down in the CSD (no: VPS), provided that the new bond issue has been paid in. This information is published in accordance with the requirements of the Continuing

PhenoSys now offers Turnkey Mini2P Systems with poLight ASA Tunable Optics

Miniature two-photon microscope enables fast, high-resolution, multi-plane calcium imaging for neurological research in freely moving animalsHORTEN, Norway -- 21 February, 2024 -- poLight ASA  (OSE: PLT) today announced that PhenoSys , a leader in engineering and market innovative technology for animal behaviour research, offers a Mini2P turnkey solution that includes TLens® for optimal microscopic imaging. The PhenoSys system includes the miniature two-photon (Mini2P) microscope body for X-Y-Z plane scanning, fiber

Invitation to presentation of Sectra’s nine-month interim report 2023/2024

Linköping, Sweden – February 21, 2024 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) invites investors, analysts, and the media to a presentation of the company’s nine-month report with President Torbjörn Kronander and CFO Jessica Holmquist.Publication of the financial report: 8:15 a.m. (CET) on March 8, 2024Report presentation: 10:00 a.m. (CET) on the same date To participate, follow the instructions on Sectra’s website investor.sectra.com/q3report2324 .  The

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 21.02.2024, 10.35 AMManagers' transactionsViking Line Abp has on February 20:th 2024] received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from aperson discharging managerial responsibilities in Viking Line Abp.Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Jakob JohanssonPosition: Member of the Board/Deputy member Issuer: Viking Line AbpLEI: 743700CUWGW42AGIDN49Notification type: INITIAL NOTIFICATION

Mexican ceramic industry giant invests in airborne water recovery to save nearly half of plant’s total water

Grupo Lamosa, one of the largest ceramics producers of the world, has purchased a system for recycling of airborne wastewater from Swedish water innovation company Drupps to be installed at one of its production plants in Peru, to achieve sustainability ambitions by increasing water efficiency and to ensure the plant's long term operational viability.Grupo Lamosa, one of the largest ceramics producers of the world, has purchased a full-scale Drupps Vapor system for recovery of water from airborne wastewater, to be installed at one of its ceramic tiles production plants in Peru.  The

Swedish psychometric test to transform Mexico's recruitment market

Companies in Mexico and Latin America face significant challenges, including high turnover of employees and low employee engagement. Jobmatch Sweden and the Mexican HR company Mia Meraki have entered into a strategic partnership to promote innovative solutions addressing these challenges and fostering sustainable recruitment processes. "Unique to Jobmatch Talent is that the test focuses on work performance and a high predictive validity. Mia Meraki identified this as a strategic opportunity to enhance its recruitment methodology in Mexico," says Klaus Olsen, CEO of Jobmatch Sweden.

PHI to BioStock: “We aim to revolutionize the regenerative medicine market “

A year ago, Patrik Eschricht assumed the role of CEO at PHI, heralding the shift towards regenerative medicine and a commitment to enhancing shareholder value. This transition was further underscored by the entry of private Swiss distributor and investment company Altium as a major shareholder. BioStock talked to Patrik Eschricht to reflect on the past year and explore his vision for the company’s future.Read the full interview with Patrik Eschricht at biostock.se: https://www.biostock.se/en/2024/02/phi-we-aim-to-revolutionize-the-regenerative-medicine-market/ This is a press release

Comintelli AB: Comintelli signs agreement with new North American customer

Stockholm, Sweden – February 21, 2024 – Comintelli AB (publ), a provider of the software platform Intelligence2day® for market intelligence and analysis, has signed a one-year license agreement with a North American technology company. The order value is USD 70k, which corresponds to ARR (Annual Recurring Revenue). "This agreement marks an important milestone in our SaaS journey and strengthens our position in the North American market," says Jesper Martell, CEO of Comintelli. "The technology industry is a strategically important industry for us and we see a strong demand for our

Taking stock: Women are leading on household budgets but not making future investments shows study

  A study has found that whilst women are leading on budget management and day to day financial planning, they are not investing for the future and less likely than men to invest in stocks and shares. The research by Readly, the digital magazine and newspaper app, reveals how Brits tackle budgeting and financial management and highlights the most popular savings and investment opportunities.   Two thirds of Brits (76 percent) consider themselves to be financially literate and engaged in financial management yet the majority are only saving between £100-500 a month and

ExpreS2ion’s Associated Company AdaptVac Receives Milestone Payment Following Completion of Bavarian Nordic’s Clinical Phase III Study for the COVID-19 Vaccine

Hørsholm, Denmark, 21 February 2024 – ExpreS[2]ion Biotech Holding AB’s affiliate ExpreS[2]ion Biotechnologies ApS (“ExpreS2ion") today announces that AdaptVac ApS (“AdaptVac”) has received 10 million EUR as a result of Bavarian Nordic having completed the clinical Phase III study of the COVID-19 vaccine ABNCoV2. The board of AdaptVac, in line with authority granted through AdaptVac’s articles of association, has agreed to resolve on the pay-out of excess capital in AdaptVac to the shareholders of AdaptVac, which are ExpreS2ion (34% share ownership) and NextGen Vaccines Holding ApS (“NextGen”)

Wulff Group Plc: Manager Transaction – Kari Juutilainen

MANAGERS’ TRANSACTIONS | FEBRUARY 21, 2024 AT 10.00 A.M. Wulff Group Plc has received a notification from Kari Juutilainen, Wulff Group Plc’s Board of Directors Chairman, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Name: Kari JuutilainenPosition: Board of Directors MemberIssuer: Wulff Group PlcLEI: 74370016PW2V4W02LX91Notification type: Initial notification

24SevenOffice Group AB expands into the Canadian market by signing two new milestone customer contracts

24SevenOffice has global ambitions and adding two new customer contracts marks its strategic entry into the Canadian market. These two customers, Capsule Factory and another global food industry producer with more than $100 million in revenues based in Canada, are following the first live Canadian customer in Q4 last year.  The Canadian market will be completely run by the existing organization in the United States. In the US and Canada it is 24SevenOffice´s MRP software module targeting the manufacturing industry which is the focus area and business vertical. Total ARR from the Canadian

ABAX appoints Tom Kocken as New M&A Director to drive Strategic Growth and enhance customer value

ABAX, a leading provider within telematics and smart mobility services, announces the appointment of Tom Kocken as its new Director of Mergers and Acquisitions (M&A), as of 1st March. This marks a significant step in ABAX’s commitment to enhancing its market position aligning with its core values of driving innovation, sustainability and delivering increased value to its customers and stakeholders.By appointing this new role ABAX aims to accelerate its growth trajectory through targeted acquisitions that complement and expand its current offerings. These strategic acquisitions are

Read original

Penneo achieves 26% year-on-year ARR growth in 2023

Company Announcement No. 7-2024Copenhagen, 21 February 2024Annual report for the period 1 January 2023 - 31 December 20232023 performance highlights · ARR increased by 18.4M DKK to 89.3M DKK corresponding to 26% year-on-year (YoY) growth at the end of the year · ARR increase from Newbiz amounted to 10.1M DKK compared to 8.5M DKK in 2022 · ARR increase from Uplift amounted to 11.4M DKK compared to 9.1M DKK in 2022 · ARR lost to Churn amounted to 3.2M DKK compared to 2.2M DKK in 2022 · ARR from foreign markets increased by 7.1M DKK compared to 5.2M DKK in 2022 · EBITDA

Össur hf: Össur establishes new parent organization to be named Embla Medical

Investor News 21 February 2024 Össur establishes new parent organization to be named Embla Medical Össur proposes to establish a new parent organization to be named Embla Medical, which will become the listed company. This change will formally be implemented by changing the name of the Össur hf. entity to Embla Medical hf. Over the years the Company has evolved and now operates across the whole value chain, serving individuals with chronic mobility challenges in need of prosthetics, neuro orthotics and bracing solutions. Today the Company operates several product and patient

Belgium’s leading outdoor retailer A.S.Adventure, new reseller of OrganoTex

OrganoClick's brand OrganoTex is being launched in the Belgian A.S.Adventure's network of stores and online platform during February.A.S.Adventure is part of the Yonderland Group, Europe's largest outdoor chain with over 190 stores, where OrganoTex is already represented with its Eco-labelled textile impregnation, as well as the range of biodegradable shoe care and detergents through the collaboration with the Dutch chain Bever. With A.S.Adventure as a new retailer, OrganoTex continues its international expansion into Belgium, aligning with OrganoClick's expansion strategy. "We are

Year-end report 2023

Strong cash flow during an otherwise challenging quarter – new action package initiated OCTOBER – DECEMBER 2023 · Net sales amounted to MSEK 311.2 (341.8). · Net sales declined 9% (-8). · EBIT amounted to MSEK -0.1 (8.9). · EBIT margin amounted to 0% (2.6). · Non-recurring costs of MSEK 9.8 (15.0) were charged to EBIT. · Non-recurring revenue from the sale of industry properties of MSEK 18 (0) is included in EBIT. · Net income was MSEK 0.1 (7.0). · Earnings per share amounted to SEK 0 (0.14). · Cash flow from operating activities amounted to MSEK 34.9 (13.0).

Immunovia Publishes Full Year Report for 2023

October-December 2023 · Net sales, which for the quarter only included royal- ties, amounted to kSEK 155 (502). · Net earnings were MSEK -49 (-67) and earnings per share before and after dilution were SEK -1.08 (-2.97). · Cash Flow from operating activities amount MSEK -28 (-51). · Cash and equivalents at the end of the period amounted to MSEK 77 (106). · On October 3, the Company announced that the Nomination Committee had been appointed to consist of the following persons who together represent 7,52 percent of the total number of outstanding shares and votes in the

Össur hf: Annual General Meeting 13 March 2024

Announcement no. 5/2024 21 February 2024 Annual General Meeting 13 March 2024 Össur hf.'s Annual General Meeting will be held on Wednesday 13 March 2024 at 9:00 AM (GMT) at the Company’s headquarters at Grjótháls 5, Reykjavík, Iceland. Enclosed is the convocation, which includes the proposed agenda for the Annual General Meeting and information on shareholders’ participation and registration, shareholders’ rights, voting and proxies, and other practical matters, as well as the proposed resolutions and remarks on each item on the agenda. Further information David

There are no items matching the current filter
There are no more items matching the current filter
Back to top